VIVIDION THERAPEUTICS
Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery. Making accessible the broad set of proteins expressed in human cells, the companyโs platform was spun out of the labs of Vividionโs scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA. Vividion is committed to advancing and applying its pioneering synthetic and proteomic chemistry platforms to create therapeutics that will make a transformative difference in patients.
VIVIDION THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2013-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.vividion.com
Total Employee:
101+
Status:
Active
Contact:
(609)924-6452
Email Addresses:
[email protected]
Total Funding:
371.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins
Similar Organizations
Aurinia Pharmaceuticals
Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Empirico
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.
Evvy
Evvy is for people with vaginas who want to be empowered with information about their microbiome.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
HYGIEIA
Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy.
Insitu Biologics
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and proprietary treatments.
InVivo Therapeutics
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.
Lenima Field Diagnostics LLC
Lenima Field Diagnostics is a developer of molecular diagnostic tests designed to offer low-cost treatments for infectious diseases.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Solace Therapeutics
Solace Therapeutics develops and commercializes non-surgical office-based treatments for common bladder disorders.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation
Current Advisors List
Current Employees Featured
Founder
Investors List
Woodline Partners
Woodline Partners investment in Series C - Vividion Therapeutics
Avoro Capital Advisors
Avoro Capital Advisors investment in Series C - Vividion Therapeutics
Logos Capital
Logos Capital investment in Series C - Vividion Therapeutics
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Vividion Therapeutics
Boxer Capital
Boxer Capital investment in Series C - Vividion Therapeutics
Acuta Capital Partners
Acuta Capital Partners investment in Series C - Vividion Therapeutics
T. Rowe Price
T. Rowe Price investment in Series C - Vividion Therapeutics
Surveyor Capital
Surveyor Capital investment in Series C - Vividion Therapeutics
Nextech Invest
Nextech Invest investment in Series C - Vividion Therapeutics
Driehaus Capital Management
Driehaus Capital Management investment in Series C - Vividion Therapeutics
Key Employee Changes
Date | New article |
---|---|
2020-02-11 | Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer |
Official Site Inspections
http://www.vividion.com Semrush global rank: 2.53 M Semrush visits lastest month: 6.96 K
- Host name: 129.181.211.130.bc.googleusercontent.com
- IP address: 130.211.181.129
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043